Who are Cogent Biosciences, Inc.'s main suppliers?

Cogent Biosciences, Inc. (COGT) key suppliers include: PLEXXIKON, Biodexa Pharmaceuticals Plc. View the full supplier network at chainsifter.com/chain/COGT.

Who are Cogent Biosciences, Inc.'s major customers?

Cogent Biosciences, Inc. (COGT) key customers include: GUGGENHEIM-SECURITIES-LLC. View the full customer network at chainsifter.com/chain/COGT.

What sector is Cogent Biosciences, Inc. in?

Cogent Biosciences, Inc. (COGT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Cogent Biosciences, Inc. (COGT) Suppliers & Customers

2Suppliers

1Customers

3Debt Items

13Related Chains

Source-Backed Evidence Depth

Cogent Biosciences, Inc. (COGT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships

1Distinct source URLs

5High confidence

0.837Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Cogent Biosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
PLEXXIKON	PLEXXIKON	92%	Under the terms of the License Agreement, the Company is required to pay Plexxikon Inc., a member of the Daiichi Sankyo Group, aggregate payments of up to $ 7.5 million upon the satisfaction of certa…
BDRX	Biodexa Pharmaceuticals Plc	72%	Reciprocal relationship from BDRX graph: Reciprocal relationship from COGT graph: Reciprocal relationship from BDRX graph: ddition of additional warnings, contraindications or other safety informatio…

Cogent Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
GUGGENHEIM-SECURITIES-LLC	GUGGENHEIM-SECURITIES-LLC	62%	ially in connection with our ongoing activities, particularly if and as we: • seek regulatory approvals for any product candidates that successfully complete clinical trials; • establish a sales, mar…

Cogent Biosciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
COGT-DEBT-8783	Warrants outstanding: 3030302	90%	xbrl warrant detail from xbrl 2025-12-31.
COGT-DEBT	Debt stack $44.2M	90%	Market cache reports total debt of $44.2M.
COGT-DEBT-8784	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2018-12-31.

Cogent Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cogent Biosciences, Inc..

Cogent Biosciences, Inc. Ownership

Holder	Name	Confidence	Evidence
COGT-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 309 tracked holders.

Cogent Biosciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
CRSP	CRISPR Therapeutics AG	100.00	2
SABS	SAB Biotherapeutics, Inc.	100.00	2
GSK	GSK plc	100.00	2
TPST	Tempest Therapeutics, Inc.	100.00	2
RXRX	Recursion Pharmaceuticals, Inc.	100.00	2
TARA	Protara Therapeutics, Inc.	50.00	2
CNSP	CNS Pharmaceuticals, Inc.	50.00	2
CGON	CG Oncology, Inc.	50.00	2
SABSW	SAB Biotherapeutics, Inc.	50.00	2
PSTV	Plus Therapeutics, Inc.	50.00	2
BDRX	Biodexa Pharmaceuticals Plc	36.29	1	['supplier']
SLN	Silence Therapeutics plc	14.78	2
MANU	Manchester	14.78	2

Cogent Biosciences, Inc. Supply Chain